BIO-FD&C Co (XKRX:251120) Debt-to-Equity : 0.02 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is BIO-FD&C Co Debt-to-Equity?

BIO-FD&C Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩1,217 Mil. BIO-FD&C Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩3 Mil. BIO-FD&C Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩59,711 Mil. BIO-FD&C Co's debt to equity for the quarter that ended in Mar. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for BIO-FD&C Co's Debt-to-Equity or its related term are showing as below:

XKRX:251120' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.06 Max: 0.26
Current: 0.02

During the past 7 years, the highest Debt-to-Equity Ratio of BIO-FD&C Co was 0.26. The lowest was 0.02. And the median was 0.06.

XKRX:251120's Debt-to-Equity is ranked better than
87.64% of 1068 companies
in the Biotechnology industry
Industry Median: 0.14 vs XKRX:251120: 0.02

BIO-FD&C Co Debt-to-Equity Historical Data

The historical data trend for BIO-FD&C Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-FD&C Co Debt-to-Equity Chart

BIO-FD&C Co Annual Data

Trend

Dec15

Dec16

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.41

0.34

0.26

0.24

0.06

BIO-FD&C Co Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial									0.06	0.04	0.04	0.02	0.02

Competitive Comparison of BIO-FD&C Co's Debt-to-Equity

For the Biotechnology subindustry, BIO-FD&C Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BIO-FD&C Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BIO-FD&C Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where BIO-FD&C Co's Debt-to-Equity falls into.

BIO-FD&C Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

BIO-FD&C Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3416.183	+	0)	/	52977.381
	=	0.06

BIO-FD&C Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1216.592	+	2.566)	/	59710.617
	=	0.02

BIO-FD&C Co (XKRX:251120) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

BIO-FD&C Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of BIO-FD&C Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BIO-FD&C Co (XKRX:251120) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

30, Songdomirae-ro, Yeonsu-gu, 509-512, B07, A-dong, Smartvalley, Incheon, KOR

Website

http://www.biofdnc.com

BIO-FD&C Co Ltd is engaged in dealing with anti-aging and health materials using sustainable bio-cultivation technology. Its products include Plant cell, Peptide, Herbal Extract and Biomolecule.

BIO-FD&C Co (XKRX:251120) Headlines

No Headlines